Back to company

Familien Andresens selskab til fremme af medicinsk forskning A/S: Financial statements 2019

CVR: 39694395

Familien Andresens selskab til fremme af medicinsk forskning A/S (CVR 39694395) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -5,529,625 and a net result of DKK -2,931,178. Equity amounted to DKK 43,504,795. The solvency ratio was 88.7%.

Gross Profit
-5,529,625 kr.
Profit/Loss
-2,931,178 kr.
Equity
43,504,795 kr.
Total Assets
49,029,795 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

Familien Andresens selskab til fremme af medicinsk forskning A/S publishes interim reportApr 12, 2019

Familien Andresens selskab til fremme af medicinsk forskning A/S has published its interim report for the period June 27, 2018 – December 31, 2018.

About Familien Andresens selskab til fremme af medicinsk forskning A/S

Familien Andresens selskab til fremme af medicinsk forskning A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 2018. The company is registered under the industry Investering for egen regning. The management consists of Jørgen Jacobsen. The company is owned by CALLIE INVEST A/S. In 2025, the company reported a gross profit of DKK -25,521,250 and a net result of DKK -19,380,900 compared with DKK -6,685,198 the year before. Equity amounted to DKK 86,296.

Other financial years